Items where authors include "Bryan, R.T."

Article

Gordon, N.S., McGuigan, E.K., Ondasova, M. et al. (12 more authors) (2024) Comparison and combination of mutation and methylation-based urine tests for bladder cancer detection. Biomarker Research, 12. 133. ISSN 2050-7771

James, N. orcid.org/0000-0002-7314-8204, Pirrie, S. orcid.org/0000-0002-2894-2230, Liu, W. orcid.org/0000-0002-6682-2053 et al. (10 more authors) (2024) Image directed redesign of bladder cancer treatment pathways: the BladderPath RCT. Health Technology Assessment, 28 (42). ISSN 1366-5278

Nanton, V. orcid.org/0000-0002-9553-822X, Bryan, R.T. orcid.org/0000-0003-2853-4293, Pope, A.M. et al. (11 more authors) (2023) Boosting and broadening recruitment to UK cancer trials: towards a blueprint for action. BMJ Oncology, 2 (1). e000092. ISSN 2752-7948

Bryan, R.T., Pirrie, S.J., Abbotts, B. et al. (26 more authors) (2023) Selenium and vitamin E for prevention of non–muscle-invasive bladder cancer recurrence and progression. JAMA Network Open, 6 (10). e2337494. ISSN 2574-3805

Mintz, H.P. orcid.org/0000-0003-1583-6268, Dosanjh, A.R.S. orcid.org/0000-0002-4522-7722, Parsons, H. orcid.org/0000-0002-2765-3728 et al. (4 more authors) (2023) Making administrative healthcare systems clinical data the future of clinical trials: lessons from BladderPath. BMJ Oncology, 2 (1). e000038. ISSN 2752-7948

Kerzeli, I.K., Kostakis, A., Türker, P. et al. (8 more authors) (2023) Elevated levels of MMP12 sourced from macrophages are associated with poor prognosis in urothelial bladder cancer. BMC Cancer, 23 (1). 605. ISSN 1471-2407

Hof, J.P., Vermeulen, S.H., van der Heijden, A.G. et al. (8 more authors) (2023) An association study of germline variants in bladder cancer-related genes with the prognosis of on-Muscle Invasive Bladder Cancer. Bladder Cancer, 9 (1). pp. 59-71. ISSN 2352-3727

Galesloot, T.E., Grotenhuis, A.J., Kolev, D. et al. (16 more authors) (2022) Genome-wide meta-analysis identifies novel genes associated with recurrence and progression in non–muscle-invasive bladder cancer. European Urology Oncology, 5 (1). pp. 70-83. ISSN 2588-9311

Birtle, A., Johnson, M., Chester, J. et al. (21 more authors) (2020) Adjuvant chemotherapy in upper tract urothelial carcinoma (the POUT trial): a phase 3, open-label, randomised controlled trial. The Lancet, 395 (10232). pp. 1268-1277. ISSN 0140-6736

Ward, D.G., Baxter, L., Gordon, N.S. et al. (15 more authors) (2016) Multiplex PCR and Next Generation Sequencing for the Non-Invasive Detection of Bladder Cancer. PLOS ONE, 11 (2). e0149756-e0149756. ISSN 1932-6203

Bryan, R.T., Evans, T., Dunn, J.A. et al. (6 more authors) (2015) A Comparative Analysis of the Influence of Gender, Pathway Delays, and Risk Factor Exposures on the Long-term Outcomes of Bladder Cancer. European Urology Focus, 1 (1). 82 - 89.

Bryan, R.T., Shimwell, N.J., Wei, W. orcid.org/0000-0003-1288-6999 et al. (7 more authors) (2014) Urinary EpCAM in urothelial bladder cancer patients: characterisation and evaluation of biomarker potential. British Journal of Cancer, 110 (3). pp. 679-685. ISSN 0007-0920

Shimwell, N.J., Bryan, R.T., Wei, W. orcid.org/0000-0003-1288-6999 et al. (6 more authors) (2013) Combined proteome and transcriptome analyses for the discovery of urinary biomarkers for urothelial carcinoma. BRITISH JOURNAL OF CANCER, 108 (9). pp. 1854-1861. ISSN 0007-0920